Galectin Therapeutics Inc. (GALT) vs Utah Medical Products, Inc. (UTMD)
A side-by-side comparison of Galectin Therapeutics Inc. and Utah Medical Products, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GALT
Galectin Therapeutics Inc.
$3.76HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
UTMD
Utah Medical Products, Inc.
$73.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — GALT vs UTMD
growth of $100 · dividends reinvested · last 10yGALT +166.4% (+10.3%/yr)UTMD +41.1% (+3.5%/yr)GALT compounded faster over this window
GALT UTMD
GALT vs UTMD: by the numbers
- •GALT is the larger company ($248M vs $235M market cap).
- •UTMD is profitable (29.04% net margin) while GALT runs a net loss (0.00%).
- •UTMD pays a dividend (1.67% yield), while GALT has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | GALT | UTMD |
|---|---|---|
| P/E ratio | N/A | 22.51 |
| PEG ratio | N/A | 6.56 |
| P/S ratio | N/A | 6.51 |
| P/B ratio | N/A | 1.93 |
| EV / EBITDA | N/A | 18.54 |
| FCF yield | N/A | 4.87% |
Profitability
| Metric | GALT | UTMD |
|---|---|---|
| Gross margin | 0.00% | 54.88% |
| Operating margin | 0.00% | 28.46% |
| Net margin | 0.00% | 29.04% |
| ROE | N/A | 8.59% |
| ROIC | -1718.59% | 6.83% |
Dividends
| Metric | GALT | UTMD |
|---|---|---|
| Dividend yield | N/A | 1.67% |
| Payout ratio | N/A | 37.80% |
Growth (annualized)
| Metric | GALT | UTMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -4.75% |
| EPS CAGR (5Y) | N/A | 3.36% |
| FCF CAGR (5Y) | N/A | -11.12% |
| Total return CAGR (5Y) | 0.60% | -2.70% |
Frequently asked
- Does GALT or UTMD pay a bigger dividend?
- UTMD pays a dividend (1.67% yield), while GALT has no payments in the available dividend history.
- Is GALT or UTMD more profitable?
- UTMD runs the higher net margin — GALT at 0.00% versus UTMD at 29.04%.
- How have GALT and UTMD total returns compared?
- Over the past 10 years, GALT delivered 13.41% and UTMD delivered 3.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Utah Medical Products P/E ratioUtah Medical Products dividend yieldGalectin Therapeutics ROEUtah Medical Products ROEGalectin Therapeutics operating marginUtah Medical Products operating marginGalectin Therapeutics revenue growthUtah Medical Products revenue growthGalectin Therapeutics free cash flowUtah Medical Products free cash flow
Galectin Therapeutics & Utah Medical Products appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.